175 related articles for article (PubMed ID: 16705487)
1. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.
Heinzerling L; von Baehr V; Liebenthal C; von Baehr R; Volk HD
J Clin Immunol; 2006 Jul; 26(4):347-59. PubMed ID: 16705487
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the stimulatory activity of a fermented mistletoe lectin-1 free mistletoe extract on T-helper cells and monocytes in healthy individuals in vitro.
Stein GM; Berg PA
Arzneimittelforschung; 1996 Jun; 46(6):635-9. PubMed ID: 8767357
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
4. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
Stein GM; Berg PA
Eur J Med Res; 1998 Jun; 3(6):307-14. PubMed ID: 9620894
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral adjuvant activity of mistletoe extract.
Bloksma N; Van Dijk H; Korst P; Willers JM
Immunobiology; 1979 Sep; 156(3):309-18. PubMed ID: 575523
[TBL] [Abstract][Full Text] [Related]
7. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.
Stein GM; Edlund U; Pfüller U; Büssing A; Schietzel M
Anticancer Res; 1999; 19(5B):3907-14. PubMed ID: 10628330
[TBL] [Abstract][Full Text] [Related]
8. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
9. Effect of a mistletoe extract (Iscador QuFrF) on viability and migratory behavior of human peripheral CD4+ and CD8+ T lymphocytes in three-dimensional collagen lattices.
Nikolai G; Friedl P; Werner M; Niggemann B; Zänker KS
In Vitro Cell Dev Biol Anim; 1997 Oct; 33(9):710-6. PubMed ID: 9358287
[TBL] [Abstract][Full Text] [Related]
10. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
Hajto T; Hostanska K; Gabius HJ
Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract].
Beuth J; Ko HL; Tunggal L; Geisel J; Pulverer G
Arzneimittelforschung; 1993 Feb; 43(2):166-9. PubMed ID: 7681287
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro.
Elsässer-Beile U; Voss M; Schühle R; Wetterauer U
J Clin Lab Anal; 2000; 14(6):255-9. PubMed ID: 11138605
[TBL] [Abstract][Full Text] [Related]
13. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
Stein GM; Berg PA
Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
[TBL] [Abstract][Full Text] [Related]
15. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
16. Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects.
Huber R; Klein R; Berg PA; Lüdtke R; Werner M
J Altern Complement Med; 2002 Dec; 8(6):857-66. PubMed ID: 12614536
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
van Wely M; Stoss M; Gorter RW
Am J Ther; 1999 Jan; 6(1):37-43. PubMed ID: 10423645
[TBL] [Abstract][Full Text] [Related]
18. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum).
Yoon TJ; Yoo YC; Kang TB; Her E; Kim SH; Kim K; Azuma I; Kim JB
Int Immunopharmacol; 2001 May; 1(5):881-9. PubMed ID: 11379043
[TBL] [Abstract][Full Text] [Related]
20. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals.
Huber R; Classen K; Werner M; Klein R
Arzneimittelforschung; 2006 Jun; 56(6A):447-56. PubMed ID: 16927525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
